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CLINIKAL EVALUATION OF PIPERACILLIN
         IN THE UROLOGICAL FIELD
Shigeaki HAyAsHiDA， Keiichi KiTAJiMA and Keiji JoKo
  From the DePartment of Urology， Toku］ama Central Hospital
               （c痂げ’8．助ashida，砿D．）
  The sensitivyty of 249 etiological bacterial strains causing inflammation isolated from
patients with infections of the urogenital tract who were under treatment on an in－patient
basis in our Department was examined by the Disc （3 concentration） assay method． Piper－
acillin （PIPC） was employed for prophylactic treatment in 18 patients against postoperativ．e
infections and for therapeutic treatment in 3 patients against complicated infections ofuroge－
nital tracts．
 ．Th． e．re．sy！｛F g． ．f Phese stgdies ar．e reported．along with some discussion on the utility of plpc
in the urological field．
  The frequency of detection of bacteria isolated from the patients on their admissien into
our hospital was in the decreasing order of StrePtocccus Sp．， Proteus Sp． and E． coli． Pseudo－
monas aeruginosa and Klebsiella Sp． also were noted in some of the patients． Pseudomenas
aeruginosa， nonfermentative Gram’s－negative bacilli （NF－GNB）， and Streptococcus Sp． were
detected in many of the patients who had had an operation or who had been in hospital
for a long time．
  The sensitivity of E． coli， Proteus Sp．， StrePtococcus Sp． and Pseudomonas aeruginesa was invari－
ably more than 80％， while that of NF－GNB was more than 50％．
  PIPG was used for prophylactic treatment of p4tients against infections at the postopera－
tive stage in the urogenical field． Out 6f 18 cases， it proved to be markedly effective in．
14cases and moderately e ff（）ctive in 4 cases。 There was no poorly e丘bcti＞e case．
  PIPC was employed for treatment in’5 cases complicated infections of urogenital tracts．
There was no markedly effective case， and 2 ’moderately effective and 3 poorly effective cases
resulted according to the UTI efficacy evaluation standarads． However， its bacteriological
efficacy could be identified in all the treated cases．
 Therefore， PIPC is a valuable prophylactic antibiotic agent against infections after an
operation in the urological field． lt may also prove valuable in the therapeutic treatment
of complicated infections in the urogenital tracts．
  PIPC has a relatively large margin of safety in terms of side effects as in the case of
conventional penicillin group antibiotics．
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sp．， Protet‘S sp．， E． coliと多く，Pseudomonas aerugi－
nosa， Klebsiella sP．もいくらか認められている．術後
工ヵ月以内ではブドウ糖非発酵グラム陰性桿菌（NF－
GNB）， Serrqtia， Pseadomonas aeruginosaとつづき，












Table 1． lsolated organisms from grine
（Urol． Tokuyama Central Hospital 1980）
OrganismAt Admission After Surgery Long term admisson





































































    Table 2．
On Admission
Disc sensitivity of E． coli to various antibiiotics
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   Table 3．
On Admission
Disc sensitivity of proteus sp． to various antibiotics
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た．MINOは高度感受性は少ないものの耐性菌は39
株中1株しか認めなかった．






 5） Pseudomonas aeruginosa Table 6に表











  Table 4． Disc sensitivity of streptococcus sp． to vatious antibiotics
On Admission
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   Table 5．
On Admission
Disc． sensiti’，tity of klebsiella sp． to various antibiotics
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             林田・ほか：ピペラシリソ・尿路感染
Table 6， Disc sensit1vity of pseudomonas aeruginosa to various antibiotics
On Admission
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    Table 7．
On Admission
Disc sensitivity of serratia sp． to various antibiotics
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     Table 8．
After Treatment
Disc sensitivity of NF－aNB to various antibiotics
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  Table 9． Antibacterial activity of various antibiotics
＞ so％ seo／o 〉※E，col藍
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くに術前に多いE．‘oli， Proteus sp．Stre Ptocσccus sp．
に対して強い感受性が認められ，かつ術後に比較的多
いPseudomonαS aeruginesa， StrePtecoceUS sp．にも強力
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Table IO－1． Operative cases treated by PIPC
















































の菌種はPseudomonas aeruginosa 1株， StaPhylocoecus



















































 D 対 象




   （ ・！nt）
Operation
    wound Oraganism in urine（ ／me） clinical
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Table 11． Clinical results




























































































Table 12．Ci．inical laboratory．一findings （Operative qases’）
No． RBC Wbe Eosinecyte’ Thronb6eyte GOT  （xlO‘／mm S） ．（ ／mm3） ’ （％） ． （XIO’／inm3）（u） GPT （u） ALK． P（ u’） BUN．（・gイdD Cr （mg／d蓋）































































































































































































































































































































































Table 13． Cases of complicated urinary tract infection treated by PIPC
Nq Sex AgeBasic diseaseGroup Dosage seheduleof UTI Daily dose Duration
1
     Bil renal stone
M 70 Bladder stone
     Neurogeni c bladder
5 2（g） ×2 5（days）
2 M 73 After prostatectomy2 2×2 5
3 M 79 After prostatectomy2 2×2 5
4      Left renal cancerM 51       advance stage1 1×2 5
5      pcM 86     After prostatectotny2 2×2 7
Table 14． Cases of complicated urinary tract infection treated by PIPC
     Before Treatment
NO・ Organism Sensitivity W B C
    ／me to PIPC in Urine
   After Treatment
Organism Sensitivity WBC Effeet
／me to PIPC in Urine
  Ps．aeruginosa 一










  Ps．aeruginosa 十梓3    106
Ps．aeruginosa 一
  los Poor





























        ま  と  め
．徳山中央病院泌尿器科入院患者のうち尿路感染症よ
り分離した原因菌249株についてDisc法による各種
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